ASCP DISCUSSES MTMS IN LONG-TERM CARE

SEPTEMBER 01, 2006

The American Society of Consultant Pharmacists (ASCP) recently addressed medication therapy management services (MTMS) in long-term care. MTMS programs are expected to (1) optimize therapeutic outcomes through improved medication use; (2) reduce the risk of adverse events, including adverse drug interactions; (3) be conducted by a pharmacist or other qualified health care provider; and (4) differentiate between services in ambulatory and institutional settings.

In its policy statement, ASCP highlighted the following points:

  • ASCP advocates that Part D sponsors provide flexibility in the MTMS offered to patients of long-term care facilities and that these services mirror the unique differences in these residents and settings
  • The MTMS program should mainly focus on optimizing therapeutic outcomes and reducing adverse drug events for the beneficiary, and secondarily focus on reductions of drug costs when necessary
  • Pharmacists who provide MTMS to long-term care facility residents should have expertise in geriatric drug therapy
  • MTMS recommendations received by the administrator, prescriber, pharmacy provider, or caregiver/resident are best reconciled by the facility's consultant pharmacist


SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.